{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:01:37Z","timestamp":1771470097129,"version":"3.50.1"},"reference-count":15,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Virus-like particles (VLPs) have become a key tool for vaccine developers and manufacturers [...]<\/jats:p>","DOI":"10.3390\/v12080872","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T05:07:23Z","timestamp":1597036043000},"page":"872","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Special Issue \u201cVirus-Like Particle Vaccines\u201d"],"prefix":"10.3390","volume":"12","author":[{"given":"Monique","family":"Vogel","sequence":"first","affiliation":[{"name":"University Hospital for Rheumatology, Immunology, and Allergology, University of Bern, 3010 Bern, Switzerland"},{"name":"Department of BioMedical Research, University of Bern, 3010 Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4370-2099","authenticated-orcid":false,"given":"Martin F.","family":"Bachmann","sequence":"additional","affiliation":[{"name":"University Hospital for Rheumatology, Immunology, and Allergology, University of Bern, 3010 Bern, Switzerland"},{"name":"Department of BioMedical Research, University of Bern, 3010 Bern, Switzerland"},{"name":"Nuffield Department of Medicine, Centre for Cellular and Molecular Physiology (CCMP), The Jenner Institute, University of Oxford, Oxford OX3 7BN, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,8,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Gonzalez-Dominguez, I., Puente-Massaguer, E., Cervera, L., and Godia, F. (2020). Quality Assessment of Virus-Like Particles at Single Particle Level: A Comparative Study. Viruses, 12.","DOI":"10.3390\/v12020223"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Balke, I., and Zeltins, A. (2020). Recent Advances in the Use of Plant Virus-Like Particles as Vaccines. Viruses, 12.","DOI":"10.3390\/v12030270"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Aves, K.L., Goksoyr, L., and Sander, A.F. (2020). Advantages and Prospects of Tag\/Catcher Mediated Antigen Display on Capsid-Like Particle-Based Vaccines. Viruses, 12.","DOI":"10.3390\/v12020185"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Pushko, P., and Tretyakova, I. (2020). Influenza Virus Like Particles (Vlps): Opportunities for H7n9 Vaccine Development. Viruses, 12.","DOI":"10.3390\/v12050518"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"C\u00e9rbulo-V\u00e1zquez, A., Arriaga-Pizano, L., Cruz-Cure\u00f1o, G., Bosc\u00f3-G\u00e1rate, I., Ferat-Osorio, E., Pastelin-Palacios, R., Figueroa-Damian, R., Castro-Eguiluz, D., Mancilla-Ramirez, J., and Isibasi, A. (2019). Medical Outcomes in Women Who Became Pregnant after Vaccination with a Virus-Like Particle Experimental Vaccine against Influenza a (H1n1) 2009 Virus Tested During 2009 Pandemic Outbreak. Viruses, 11.","DOI":"10.3390\/v11090868"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Malm, M., Vesikari, T., and Blazevic, V. (2019). Simultaneous Immunization with Multivalent Norovirus Vlps Induces Better Protective Immune Responses to Norovirus Than Sequential Immunization. Viruses, 11.","DOI":"10.3390\/v11111018"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ho, J.K., Jeevan-Raj, B., and Netter, H.J. (2020). Hepatitis B Virus (Hbv) Subviral Particles as Protective Vaccines and Vaccine Platforms. Viruses, 12.","DOI":"10.3390\/v12020126"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Li, Y., Huang, X., Zhang, Z., Li, S., Zhang, J., Xia, N., and Zhao, Q. (2020). Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation. Viruses, 12.","DOI":"10.3390\/v12010109"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Perotti, M., and Perez, L. (2020). Virus-Like Particles and Nanoparticles for Vaccine Development against Hcmv. Viruses, 12.","DOI":"10.3390\/v12010035"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Yadav, R., Zhai, L., and Tumban, E. (2020). Virus-Like Particle-Based L2 Vaccines against Hpvs: Where Are We Today?. Viruses, 12.","DOI":"10.3390\/v12010018"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Wu, F., Zhang, S., Zhang, Y., Mo, R., Yan, F., Wang, H., Wong, G., Chi, H., Wang, T., and Feng, N. (2020). A Chimeric Sudan Virus-Like Particle Vaccine Candidate Produced by a Recombinant Baculovirus System Induces Specific Immune Responses in Mice and Horses. Viruses, 12.","DOI":"10.3390\/v12010064"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Chackerian, B., and Peabody, D.S. (2020). Factors That Govern the Induction of Long-Lived Antibody Responses. Viruses, 12.","DOI":"10.3390\/v12010074"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Caldeira, J.C., Perrine, M., Pericle, F., and Cavallo, F. (2020). Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines. Viruses, 12.","DOI":"10.3390\/v12050488"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Foerster, J., and Moleda, A. (2020). Virus-Like Particle-Mediated Vaccination against Interleukin-13 May Harbour General Anti-Allergic Potential Beyond Atopic Dermatitis. Viruses, 12.","DOI":"10.3390\/v12040438"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Thoms, F., Haas, S., Erhart, A., Nett, C.S., Rufenacht, S., Graf, N., Strods, A., Patil, G., Leenadevi, T., and Fontaine, M.C. (2020). Immunization of Cats against Fel D 1 Results in Reduced Allergic Symptoms of Owners. Viruses, 12.","DOI":"10.3390\/v12030288"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/8\/872\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:58:33Z","timestamp":1760176713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/8\/872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,10]]},"references-count":15,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8]]}},"alternative-id":["v12080872"],"URL":"https:\/\/doi.org\/10.3390\/v12080872","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,10]]}}}